Browsing Tag
neuroplastogens
2 posts
How Johns Hopkins IRB approval strengthens Clearmind Medicine’s clinical credibility in addiction medicine
Clearmind Medicine’s Johns Hopkins-backed CMND-100 trial expansion could reshape addiction therapeutics. Discover what industry observers are watching next.
Why Enveric Biosciences (NASDAQ: ENVB) may still be overlooked despite PTSD trial progress
Enveric stock dips despite FDA and PTSD progress on EB-003. Find out why investors are cautious and what milestones could restore confidence.